pharmaceuticals

Global Custom Market Research Reports Provider Company

phone

Akers Biosciences Inc (AKER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 35
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA chlamydia, PIFA dengue fever, PIFA malaria, PIFA syphilis, PIFA heparin, and breath ketone. ABI provides testing platform technologies that include MPC biosensor, particle immune-filtration assay, rapid enzymatic assay, minDNA, and synthetic macrocycle complex. The company also offers seraSTAT rapid blood cell separation, a sample preparation technology. ABI is headquartered in West Deptford, New Jersey, the US.

Akers Biosciences Inc (AKER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Akers Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Akers Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 8
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 10
Akers Biosciences Raises USD2.1 Million in Private Placement of Shares upon Exercise of Warrants 11
Akers Biosciences Completes Public Offering Of Shares For US$15 Million 12
Akers Biosciences Inc - Key Competitors 13
Akers Biosciences Inc - Key Employees 14
Akers Biosciences Inc - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Recent Developments 16
Financial Announcements 16
Apr 03, 2018: Akers Biosciences Reports Earnings for Fiscal Year 2017 16
Nov 15, 2017: Akers Biosciences Announces Q3 2017 Earnings 21
Aug 15, 2017: Akers Biosciences: Financial Results for the Six Months Ended June 30, 2017 30
Aug 03, 2017: Akers Biosciences Announces Second Quarter Trading Update 32
Corporate Communications 33
Aug 08, 2017: Akers Biosciences Announces Board Changes 33
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List Of Tables

List of Tables
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Akers Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Akers Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 8
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 10
Akers Biosciences Raises USD2.1 Million in Private Placement of Shares upon Exercise of Warrants 11
Akers Biosciences Completes Public Offering Of Shares For US$15 Million 12
Akers Biosciences Inc, Key Competitors 13
Akers Biosciences Inc, Key Employees 14
Akers Biosciences Inc, Subsidiaries 15
Akers Biosciences Inc, Joint Venture 15

List Of Figures

List of Figures
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Akers Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Akers Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 8

In this report, the Asia-Pacific Low Profile Speakers market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025,

View Report

In this report, the Asia-Pacific Computer Speakers market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing

View Report

In this report, the United States External Cardiac Pacemakers market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports